Divi's Laboratories Ltd

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Divi's Laboratories Ltd has already paid €0.27 in dividends. The last payout was in August.

Financials

In the last quarter, Divi's Laboratories Ltd had revenue of €284.32M and net profit of €83.27M

(EUR)	June 2026	YoY
Revenue	284.32M	19.17%
Gross profit	143.36M	0.40%
Net profit	83.27M	54.33%
EBITDA	115.85M	38.01%

Fundamentals

Metric	Value
Market capitalization	€25.74B
Number of shares	265.54M
52-week high/low	€97.01 - €53.94
Dividend yield	193.75%
Dividends TTM	€0.27
Beta	0.23
P/E ratio	92.00
PEG ratio	3.42
P/B ratio	16.06
P/S ratio	23.97

Company profile

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is headquartered in Hyderabad, India.

Name	Divi's Laboratories Ltd
CEO	Kiran Satchandra Divi
Headquarters	Hyderabad, ts India
Website	divislabs.com
Sector	Health Care
Industry	Pharmaceuticals
IPO	03/12/2003
Employees	11,565